ATE531386T1 - Medikament und formulierung dieses enhaltend zur verringerung oder verhinderung von atherosklerose - Google Patents

Medikament und formulierung dieses enhaltend zur verringerung oder verhinderung von atherosklerose

Info

Publication number
ATE531386T1
ATE531386T1 AT09750681T AT09750681T ATE531386T1 AT E531386 T1 ATE531386 T1 AT E531386T1 AT 09750681 T AT09750681 T AT 09750681T AT 09750681 T AT09750681 T AT 09750681T AT E531386 T1 ATE531386 T1 AT E531386T1
Authority
AT
Austria
Prior art keywords
medication
reducing
formulation containing
containing same
preventing atherosclerosis
Prior art date
Application number
AT09750681T
Other languages
English (en)
Inventor
Hikaru Ishii
Original Assignee
Hikaru Ishii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hikaru Ishii filed Critical Hikaru Ishii
Application granted granted Critical
Publication of ATE531386T1 publication Critical patent/ATE531386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT09750681T 2008-05-20 2009-05-19 Medikament und formulierung dieses enhaltend zur verringerung oder verhinderung von atherosklerose ATE531386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008131621A JP2009280508A (ja) 2008-05-20 2008-05-20 血管老化抑制剤および老化防止抑制製剤
PCT/JP2009/059490 WO2009142319A1 (en) 2008-05-20 2009-05-19 Vascular aging inhibitor and anti-aging formulation

Publications (1)

Publication Number Publication Date
ATE531386T1 true ATE531386T1 (de) 2011-11-15

Family

ID=40890739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09750681T ATE531386T1 (de) 2008-05-20 2009-05-19 Medikament und formulierung dieses enhaltend zur verringerung oder verhinderung von atherosklerose

Country Status (12)

Country Link
US (1) US20110092432A1 (de)
EP (1) EP2276504B1 (de)
JP (1) JP2009280508A (de)
KR (1) KR20110013489A (de)
CN (1) CN102014949A (de)
AT (1) ATE531386T1 (de)
AU (1) AU2009250386B2 (de)
DK (1) DK2276504T3 (de)
ES (1) ES2374602T3 (de)
RU (1) RU2455022C1 (de)
TW (1) TWI388331B (de)
WO (1) WO2009142319A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3058142B1 (fr) * 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CN114316029B (zh) * 2022-01-27 2023-06-27 西安巨子生物基因技术股份有限公司 透皮吸收性肽及通过该肽的重复构建的重组胶原蛋白

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812992D0 (en) * 1988-06-01 1988-07-06 Natural Resources Mfg Ltd Improvements in/relating to protein products
FR2678624A1 (fr) * 1991-07-04 1993-01-08 Coletica Utilisation de la peau non pigmentee de poisson, en particulier de poisson plat comme nouvelle source industrielle de collagene, procede d'extraction, collagene et biomateriau ainsi obtenus.
JP4236850B2 (ja) * 2002-02-15 2009-03-11 焼津水産化学工業株式会社 魚類由来のコラーゲンペプチドの製造方法並びに該製造方法により得られた魚類由来のコラーゲンペプチドを含有する飲食品及び化粧品
US20060078532A1 (en) * 2004-10-12 2006-04-13 Omoigui Osemwota S Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
JP4301100B2 (ja) * 2004-07-21 2009-07-22 セイコーエプソン株式会社 レイアウト要素の配置装置、レイアウト要素の配置方法、及びレイアウト要素の配置プログラム
JP4253296B2 (ja) * 2004-12-16 2009-04-08 尚文 石川 健康美容食品
CN101061827B (zh) * 2006-04-30 2012-01-25 中国食品发酵工业研究院 从鱼皮、鱼骨中酶法制取鱼胶原肽的工业生产方法
SG176466A1 (en) * 2006-11-15 2011-12-29 Meiji Seika Kaisha Collagen peptide composition and food or beverage containing the same

Also Published As

Publication number Publication date
US20110092432A1 (en) 2011-04-21
AU2009250386B2 (en) 2012-09-13
ES2374602T3 (es) 2012-02-20
KR20110013489A (ko) 2011-02-09
AU2009250386A1 (en) 2009-11-26
RU2455022C1 (ru) 2012-07-10
WO2009142319A1 (en) 2009-11-26
EP2276504B1 (de) 2011-11-02
HK1147057A1 (en) 2011-07-29
TW201000111A (en) 2010-01-01
CN102014949A (zh) 2011-04-13
JP2009280508A (ja) 2009-12-03
EP2276504A1 (de) 2011-01-26
TWI388331B (zh) 2013-03-11
DK2276504T3 (da) 2012-02-06

Similar Documents

Publication Publication Date Title
ATE482726T1 (de) Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz
BR112012018761A2 (pt) estruturas para prevenir fixação de microorganismos
AU2018260835A1 (en) Low molecular weight silk compositions and stabilizing silk compostions
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
PH12013501892A1 (en) Nutritional compositions including branched chain fatty acids for wound healing
EA201170651A1 (ru) Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин
BRPI0916693A2 (pt) uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição cosmética e/ou dermatológica, e, método de tratamento cosmético
EA201000078A1 (ru) Инъекционная дерматологическая композиция для лечения морщин
UY34645A (es) Control de microorganismos fitopatogénicos con pseudomonas sp. y sustancias y composiciones derivad as de las mismas
WO2010030714A8 (en) Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
UA108835C2 (uk) Спосіб отримання суміші похідних лактиду
DE602007005233D1 (de) Verfahren zur herstellung von l-aminosäure
ATE531769T1 (de) Verwendung von estern als koaleszenzmittel
UA104899C2 (uk) Консервант для води та корму
MX390974B (es) Uso cosmético o dermatológico de naringenina para combatir efectos de envejecimiento de la piel.
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
UA111148C2 (uk) Сигма-ліганди для застосування при профілактиці і/або лікуванні післяопераційного болю
BRPI0816796A2 (pt) Composição antibacteriana compreendendo um agente antibacteriano baseado em ésteres de ácido graxo de ácido hidróxi carboxílico.
ATE481961T1 (de) Dehydracetsäure enthaltende hautpflegezusammensetzungen mit niedrigem ph
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
MY161419A (en) Skin collagen production-promoting agent
ATE531386T1 (de) Medikament und formulierung dieses enhaltend zur verringerung oder verhinderung von atherosklerose
BR112014014572A2 (pt) composição bioativa
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
WO2013006558A3 (en) Compositions and methods for treating skeletal myopathy

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2276504

Country of ref document: EP